Covid-19: India approves Phase 3 clinical trials of Sanofi-GSK protein-based vaccine candidate
Amidst fears of newer variants of Covid-19 and vaccine availability problems, addition of another vaccine has the potential to boost the fight against Coronavirus. In a crucial development that has the potential to add another Covid vaccine to the Indian basket, French pharma company Sanofi and British pharma major GlaxoSmithKline’s joint Covid-19 vaccine candidate will … Read more